HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.26

Change

-0.07 (-0.84)%

Market Cap

N/A

Volume

300.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

+0.04 (+0.12%)

CAD 5.85B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.03 (-0.06%)

CAD 5.48B
PHYS-U:CA Sprott Physical Gold Trust

+0.44 (+2.20%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.14 (-0.38%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.16 (+0.36%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.15 (+1.55%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.03 (-0.06%)

CAD 2.98B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.09 (+0.40%)

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.71% 7% C- 18% F
Dividend Return 4.83% 78% C+ 67% D+
Total Return 2.12% 9% A- 19% F
Trailing 12 Months  
Capital Gain -2.71% 7% C- 18% F
Dividend Return 4.83% 78% C+ 67% D+
Total Return 2.12% 9% A- 19% F
Trailing 5 Years  
Capital Gain 1.23% 30% F 40% F
Dividend Return 39.32% 94% A 93% A
Total Return 40.54% 57% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 3.63% 54% F 46% F
Dividend Return 4.24% 55% F 43% F
Total Return 0.61% 83% B 35% F
Risk Return Profile  
Volatility (Standard Deviation) 7.33% 67% D+ 83% B
Risk Adjusted Return 57.87% 74% C 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike